UBE2D3-AS1

Across TCGA pan-cancer cohorts, UBE2D3-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated UBE2D3-AS1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher UBE2D3-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBE2D3-AS1 expression acts as an unfavorable survival marker, although some lineages such as THYM and ESCA show a favorable association.

STAD, LGG, and UVM are the cancer types where UBE2D3-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Median	IV	0.153	0.634	.001	103	view →
LGG	DFS	Median	All	0.657	0.816	<.001	54	view →
UVM	DFS	Median	III,IV	0.464	0.838	.004	35	view →
LIHC	OS	Median	All	0.617	0.750	.001	32	view →
THYM	DFS	Median	All	1.000	0.633	<.001	31	view →
SKCM	OS	Tertile	III,IV	0.745	0.943	.002	31	view →
ACC	DFS	Tertile	All	0.228	0.624	.005	22	view →
ESCA	DFS	Tertile	II,III,IV	0.828	0.127	.022	18	view →
KIRP	DFS	Tertile	IV	0.172	0.574	.010	17	view →
COAD	DFS	Median	II,III,IV	0.706	0.840	.015	12	view →
KIRC	DFS	Median	III,IV	0.670	0.816	.006	10	view →
BRCA	DFS	Median	All	0.461	0.586	.028	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

UBE2D3-AS1–STAD (DFS)

Open the STAD breakdown →